相关实验视频

Updated: Jun 4, 2025

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration

Published on: February 27, 2018

阿基塔胺可以通过TGF-β1激活缓解患有术后认知功能障碍的小鼠的认知障碍和脱髓化

Ting-Ting Zhu¹, Ming-Ming Zhao¹, Dan Xu²

¹Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan; Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; Neuroscience Research Institute, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China.

Progress in neuro-psychopharmacology & biological psychiatry

|December 24, 2024

概括

阿基胺有效地通过改善记忆力和减少大脑脱髓化来治疗术后认知功能障碍 (POCD). 它的治疗效果通过转化增长因子β1 (TGF-β1) 来调解,提供了一个有前途的新治疗途径.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
细胞生物学细胞生物学

背景情况:

手术后认知功能障碍 (POCD) 是手术后的一种常见并发症,其特点是认知能力下降.
目前,没有有效的治疗药物可用于POCD.
在临床前研究中,甲基胺,甲基胺的 (R) 反体,在认知增强方面表现出潜在的潜力.

研究的目的:

在POCD小鼠模型中研究阿基塔胺在改善认知缺陷方面的疗效.
探索转化生长因子β1 (TGF-β1) 在阿基塔胺对POCD的治疗作用中的作用.
评估阿基塔胺对与POCD相关的脱髓化的影响.

主要方法:

建立POCD的小鼠模型,表现出认知障碍和体脱髓化.
给POCD小鼠使用单剂量阿基胺 (10mg/kg).
使用RepSox (10 mg/kg) 抑制TGF-β受体1,以评估其对阿基塔胺疗效的影响.
内注射TGF-β1 (3.0μg/kg) 给POCD小鼠.

主要成果:

阿基塔胺治疗显著改善了POCD小鼠的认知功能,并减少了POCD小鼠的体中脱髓化.
使用RepSox的预处理阻断了阿基胺的有益作用,表明TGF-β1依赖的机制.
单独注射TGF-β1可缓解POCD小鼠的认知障碍和脱髓化.

结论:

阿基塔胺在治疗术后认知功能障碍 (POCD) 中显示出显著的治疗潜力.
阿基胺在POCD中的有益作用通过转化生长因子β1 (TGF-β1) 依赖的途径进行介导.
阿基塔胺是进一步临床研究作为POCD治疗的有希望的候选药物.

关键词:

阿基塔胺是一种阿基塔胺.脱乙烯化脱乙烯化脱乙烯化手术后的认知功能障碍外科手术手术手术在TGF-β1中.

更多相关视频

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits

Published on: March 16, 2016

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis

Published on: December 21, 2013

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.